Keywords: novo, norditropin, cleared, usa, nordisk, been, market

Novo's Norditropin Cleared In USA

Article | 06 January 1997

- Novo Nordisk has been cleared to market its recombinant humangrowth hormone product, Norditropin, in the USA. This latest development, ordered ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Novo Nordisk

Genentech

Go to company listing

Related Drugs

Somatropin Injection

Norditropin

Antihemophilic Factor

Recombinant

Coagulation Factor VIIa

Go to drug listing